正川股份(603976.SH)提示風險:注意限售股上市流通對二級市場衝擊的風險
格隆匯 7 月 27日丨正川股份(603976.SH)發佈股票交易風險提示公告,公司生產經營及主營業務未發生重大變化;經核查,目前公司未接到相關市場傳聞的疫苗瓶批量採購訂單。同時根據目前實際情況,即使公司短期內接到相關採購訂單,預計採購數量也相對有限,實際產生效益有限,不會對公司經營成果產生重大影響;
公司近期股價連續漲幅較大,且明顯高於行業內大部分公司,自2020年6月1日至公告披露日,公司股價已上漲229.11%。同時市盈率水平遠高於同行業水平,敬請廣大投資者注意二級市場交易風險,理性決策,審慎投資;
限售股上市流通對二級市場衝擊的風險。2020年8月24日,公司首次公開發行的限售股即將上市流通,本次限售股上市流通數量總共為1.129億股,佔公司總股本比例的74.67%。此次限售股上市流通數量較多,公司特別提醒投資者,注意二級市場交易風險
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.